This company listing is no longer active
Dingdang Health Technology Group Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
Dingdang Health Technology Group's earnings have been declining at an average annual rate of -0.9%, while the Consumer Retailing industry saw earnings growing at 18.3% annually. Revenues have been growing at an average rate of 6.3% per year.
Anahtar bilgiler
-0.9%
Kazanç büyüme oranı
26.7%
EPS büyüme oranı
Consumer Retailing Sektör Büyümesi | 28.3% |
Gelir büyüme oranı | 6.3% |
Özkaynak getirisi | -10.5% |
Net Marj | -4.1% |
Son Kazanç Güncellemesi | 30 Jun 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Gelir ve Gider Dağılımı
Dingdang Health Technology Group nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
30 Jun 24 | 4,877 | -198 | 1,756 | 59 |
31 Mar 24 | 4,867 | -212 | 1,740 | 62 |
31 Dec 23 | 4,857 | -226 | 1,724 | 65 |
30 Sep 23 | 4,722 | -1,297 | 1,690 | 69 |
30 Jun 23 | 4,587 | -2,368 | 1,655 | 73 |
31 Mar 23 | 4,465 | -2,491 | 1,670 | 82 |
31 Dec 22 | 4,329 | -2,833 | 1,687 | 89 |
30 Sep 22 | 4,177 | -1,951 | 1,780 | 93 |
30 Jun 22 | 4,025 | -1,069 | 1,873 | 96 |
31 Mar 22 | 3,886 | -1,232 | 1,844 | 99 |
31 Dec 21 | 3,679 | -1,578 | 1,727 | 96 |
31 Dec 20 | 2,229 | -924 | 838 | 82 |
31 Dec 19 | 1,276 | -277 | 531 | 52 |
31 Dec 18 | 585 | -108 | 272 | 31 |
Kaliteli Kazançlar: 9886 is currently unprofitable.
Büyüyen Kar Marjı: 9886 is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: 9886 is unprofitable, and losses have increased over the past 5 years at a rate of 0.9% per year.
Büyüme Hızlandırma: Unable to compare 9886's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: 9886 is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Retailing industry (-8.4%).
Özkaynak Getirisi
Yüksek ROE: 9886 has a negative Return on Equity (-10.47%), as it is currently unprofitable.